Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Enhancing access to alcohol use disorder pharmacotherapy and treatment in primary care settings: ADaPT-PC.

Hagedorn HJ, Brown R, Dawes M, Dieperink E, Myrick DH, Oliva EM, Wagner TH, Wisdom JP, Harris AH.

Implement Sci. 2016 May 10;11(1):64. doi: 10.1186/s13012-016-0431-5.

2.

Mu-opioid receptor activation in the medial shell of nucleus accumbens promotes alcohol consumption, self-administration and cue-induced reinstatement.

Richard JM, Fields HL.

Neuropharmacology. 2016 Sep;108:14-23. doi: 10.1016/j.neuropharm.2016.04.010. Epub 2016 Apr 14.

PMID:
27089981
3.

The impact of treatment condition and the lagged effects of PTSD symptom severity and alcohol use on changes in alcohol craving.

Kaczkurkin AN, Asnaani A, Alpert E, Foa EB.

Behav Res Ther. 2016 Apr;79:7-14. doi: 10.1016/j.brat.2016.02.001. Epub 2016 Feb 15.

PMID:
26905901
4.

Optimal management for alcoholic liver disease: Conventional medications, natural therapy or combination?

Kim MS, Ong M, Qu X.

World J Gastroenterol. 2016 Jan 7;22(1):8-23. doi: 10.3748/wjg.v22.i1.8. Review.

5.

The Diffusion of Acamprosate for the Treatment of Alcohol Use Disorder: Results From a National Longitudinal Study.

Knudsen HK, Roman PM.

J Subst Abuse Treat. 2016 Mar;62:62-7. doi: 10.1016/j.jsat.2015.10.005. Epub 2015 Dec 1.

PMID:
26689318
6.

Alcohol liver disease: A review of current therapeutic approaches to achieve long-term abstinence.

García ML, Blasco-Algora S, Fernández-Rodríguez CM.

World J Gastroenterol. 2015 Jul 28;21(28):8516-26. doi: 10.3748/wjg.v21.i28.8516. Review.

7.

The BDNF Valine 68 to Methionine Polymorphism Increases Compulsive Alcohol Drinking in Mice That Is Reversed by Tropomyosin Receptor Kinase B Activation.

Warnault V, Darcq E, Morisot N, Phamluong K, Wilbrecht L, Massa SM, Longo FM, Ron D.

Biol Psychiatry. 2016 Mar 15;79(6):463-73. doi: 10.1016/j.biopsych.2015.06.007. Epub 2015 Jun 12.

PMID:
26204799
8.

Addiction pharmacogenetics: a systematic review of the genetic variation of the dopaminergic system.

Patriquin MA, Bauer IE, Soares JC, Graham DP, Nielsen DA.

Psychiatr Genet. 2015 Oct;25(5):181-93. doi: 10.1097/YPG.0000000000000095. Review.

PMID:
26146874
9.

Impact of binge alcohol on mortality among people who inject drugs.

Johnson C, Dong H, Ahamad K, Hayashi K, Milloy MJ, Kerr T, Wood E.

Addict Behav Rep. 2015 Dec 1;2:28-32.

PMID:
26097893
10.

Adoption of injectable naltrexone in U.S. substance use disorder treatment programs.

Aletraris L, Bond Edmond M, Roman PM.

J Stud Alcohol Drugs. 2015 Jan;76(1):143-51.

11.
12.

Genetic markers associated with abstinence length in alcohol-dependent subjects treated with acamprosate.

Karpyak VM, Biernacka JM, Geske JR, Jenkins GD, Cunningham JM, Rüegg J, Kononenko O, Leontovich AA, Abulseoud OA, Hall-Flavin DK, Loukianova LL, Schneekloth TD, Skime MK, Frank J, Nöthen MM, Rietschel M, Kiefer F, Mann KF, Weinshilboum RM, Frye MA, Choi DS.

Transl Psychiatry. 2014 Oct 7;4:e462. doi: 10.1038/tp.2014.103.

13.

Acamprosate-induced Extrapyramidal Symptoms in an Elderly Patient with Alcohol Dependence.

Woo J, Rim HD.

Clin Psychopharmacol Neurosci. 2014 Aug;12(2):166-8. doi: 10.9758/cpn.2014.12.2.166. Epub 2014 Aug 12.

14.

Alcohol use disorders and current pharmacological therapies: the role of GABA(A) receptors.

Liang J, Olsen RW.

Acta Pharmacol Sin. 2014 Aug;35(8):981-93. doi: 10.1038/aps.2014.50. Review.

15.

A Bayesian mixed-treatment comparison meta-analysis of treatments for alcohol dependence and implications for planning future trials.

DeSantis SM, Zhu H.

Med Decis Making. 2014 Oct;34(7):899-910. doi: 10.1177/0272989X14537558. Epub 2014 Jun 16. Review.

16.

Targeting central melanocortin receptors: a promising novel approach for treating alcohol abuse disorders.

Olney JJ, Navarro M, Thiele TE.

Front Neurosci. 2014 Jun 3;8:128. doi: 10.3389/fnins.2014.00128. eCollection 2014. Review.

17.

Inhibition of phosphodiesterase 4 reduces ethanol intake and preference in C57BL/6J mice.

Blednov YA, Benavidez JM, Black M, Harris RA.

Front Neurosci. 2014 May 27;8:129. doi: 10.3389/fnins.2014.00129. eCollection 2014.

18.

Potent inhibition of alcohol self-administration in alcohol-preferring rats by a κ-opioid receptor antagonist.

Cashman JR, Azar MR.

J Pharmacol Exp Ther. 2014 Jul;350(1):171-80. doi: 10.1124/jpet.114.214262. Epub 2014 May 9.

19.

Effects of systemic opioid receptor ligands on ethanol- and sucrose seeking and drinking in alcohol-preferring (P) and Long Evans rats.

Henderson-Redmond A, Czachowski C.

Psychopharmacology (Berl). 2014 Nov;231(22):4309-21. doi: 10.1007/s00213-014-3571-9. Epub 2014 Apr 26.

20.
Items per page

Supplemental Content

Write to the Help Desk